Wagner, M., Othus, M., Patel, S., Ryan, C., Sangal, A., Powers, B., Budd, G., Victor, A., Hsueh, C., Chugh, R., Nair, S., Leu, K., Agulnik, M., Sharon, E., Mayerson, E., Plets, M., Blanke, C., Streicher, H., Chae, Y. K., & Kurzrock, R. (n.d.). 795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). Journal for immunotherapy of cancer, 8, A843. http://access.bl.uk/ark:/81055/vdc_100144730134.0x000007